AFFITECH A/S: Financial statements 2012
CVR: 14538372
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
AFFITECH A/S (CVR 14538372) has filed annual accounts for 2012. In 2012, the company reported revenue of DKK 6,123,436 and a net result of DKK -18,972,894. The profit margin was -309.8%. Equity in the 2012 report amounted to DKK 66,837,065. The solvency ratio was 68.4%.
- Revenue
- DKK 6,123,436
- Gross Profit
- DKK -13,446,724
- Profit/Loss
- DKK -18,972,894
- Equity
- DKK 66,837,065
- Total Assets
- DKK 97,754,820
Official annual report
Keep an eye on AFFITECH A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of April 27, 2012, Egor Vasetskiy is registered as vice chairman of AFFITECH A/S.
As of April 27, 2012, Keith Graham McCullagh has stepped down as vice chairman of AFFITECH A/S.
About AFFITECH A/S
AFFITECH A/S was a Danish company of the type Aktieselskab based in København N, founded in 1990. The company has been dissolved on 2 January 2023. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company was previously named PHARMEXA A/S and M&E BIOTECH A/S. The company has 0 employees (2014). In 2021, the company reported a net result of DKK 20,593,000 compared with DKK 124,803,222 the year before. Equity in the 2021 report amounted to DKK 149,159,000.